6 completed, 2 terminated, 1 recruiting. 9 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 6, Terminated 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Eating Disorders: new trials by email Literature Review of Eating Disorders trials Research Report on Eating Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Eating Disorder Chatbot Optimization Digital Chatbot Program - Eating Disorders | Phase 2 | Recruiting | Washington University School of Medicine | 800 | 2026-07-17 | 2026-07-21 |
| Oral Naltrexone In Pediatric Eating Disorders Naltrexone Hydrochloride, Control - Anorexia Nervosa/Bulimia, Anorexia in Adolescence | Phase 2 / Phase 3 | Terminated | Rosemary Claire Roden | 9 | 2022-04-22 | 2025-08-19 |
| Binge Eating & Birth Control Drospirenone-Ethinyl Estradiol Oral Tablet - Bulimia Nervosa, Binge Eating | Phase 2 | Terminated | University of North Carolina, Chapel Hill | 8 | 2020-09-24 | 2022-07-26 |
| The Role of Estrogen in the Neurobiology of Eating Disorders 17-β estradiol transdermal patches, Placebo Patch, Micronized progesterone 200 MG - Eating Disorders, Hypoestrogenemia | Phase 2 | Completed | Massachusetts General Hospital | 122 | 2019-06-13 | 2026-11-05 |
| A Relapse Prevention Program for Reducing Relapse and Fear of Food in People With Anorexia Nervosa Food Exposure Therapy and Ritual Prevention with Motivational Enhancement for Relapse Prevention in Anorexia Nervosa (AN-EX/RP), Cognitive behavioral therapy (CBT) - Eating Disorders | Phase 1 / Phase 2 | Completed | New York State Psychiatric Institute | 34 | 2007-12-01 | 2012-05-11 |
| Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa Recombinant Human Growth Hormone, Placebo for Recombinant Human Growth Hormone - Anorexia Nervosa, Osteopenia | Phase 2 | Completed | Massachusetts General Hospital | 21 | 2006-01-01 | 2020-09-02 |
| Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa Olanzapine, Placebo - Eating Disorders | Phase 2 | Completed | New York State Psychiatric Institute | 23 | 2005-10-01 | 2019-05-10 |
| Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa Erythromycin, Placebo - Bulimia Nervosa, Eating Disorders | Phase 2 | Completed | New York State Psychiatric Institute | 29 | 2004-09-01 | 2018-08-20 |
| Comparing the Effectiveness of Three Types of Therapy for the Treatment of Anorexia Nervosa in Adolescents Family therapy (FT), Individual therapy (IT) - Eating Disorders | Phase 2 | Completed | University of Chicago | 121 | 2004-04-01 | 2016-06-20 |
Feeding and Eating Disorders (9) · Anorexia Nervosa (6) · Bulimia Nervosa (3) · Binge-Eating Disorder (2) · Bulimia (2) · Amenorrhea (1) · Anorexia (1) · Bone Diseases, Metabolic (1) · Impulsive Behavior (1) · Osteoporosis (1)
Mental Disorders (9) · Pathological Conditions, Signs and Symptoms (9) · Signs and Symptoms (9) · Signs and Symptoms, Digestive (9) · Hyperphagia (2) · Behavior (1) · Bone Diseases (1) · Menstruation Disturbances (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1)
Cognitive Behavioral Therapy (1) · Erythromycin (1) · Family Therapy (1) · Growth Hormone (1) · Naltrexone (1) · Olanzapine (1) · Progesterone (1) · Secondary Prevention (1) · drospirenone and ethinyl estradiol combination (1) · methylcobalamin-coenzyme M methyltransferase (1)
New York State Psychiatric Institute (3) · Massachusetts General Hospital (2) · Rosemary Claire Roden (1) · University of Chicago (1) · University of North Carolina, Chapel Hill (1) · Washington University School of Medicine (1)
United States (9)
Anne Klibanski, MD (1) · B. T. Walsh, MD (1) · Daniel Le Grange, PhD (1) · Ellen Fitzsimmons-Craft, Ph.D. (1) · Evelyn Attia, MD (1) · Jessica Baker, PhD (1) · Joanna E. Steinglass, MD (1) · Madhusmita Misra, M.D., M.P.H. (1) · Rosemary C Roden, MD (1)
PMID 20570701, PMID 21426603, PMID 24488838, PMID 36167287, PMID 40294815
R01MH042206 (1), R01MH070620 (1), R01MH082736 (1), R01MH116205 (1), R21MH069868 (1)